Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 2, 2008, Pages 375-379

  Kim, Jung Jin ^a   Mandelli, Laura ^b   Pae, Chi Un ^a,c   De Ronchi, Diana ^b   Jun, Tae Youn ^a   Lee, Chul ^a   Paik, In Ho ^a   Patkar, Ashwin A ^c   Steffens, David ^c   Serretti, Alessandro ^b   Han, Changsu ^c,d  

^a The Catholic University of Korea   (South Korea)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d Korea University Ansan Hospital   (South Korea)

Author keywords

Dysbindin gene; Haplotype; Major depression

Indexed keywords

DYSBINDIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; CASE-CONTROL STUDIES; CONTROL GROUPS; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; KOREA; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; VARIATION (GENETICS);

EID: 38749109290     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.09.002     Document Type: Article

References (41)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, (DSM-IV). fourth ed (1994), American Psychiatric Press, Washington DC
2. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
3. Benson M.A., Newey S.E., Martin-Rendon E., Hawkes R., and Blake D.J. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 276 26 (2001) 24232-24241
4. Blake D.J., Hawkes R., Benson M.A., and Beesley P.W. Different dystrophin-like complexes are expressed in neurons and glia. J Cell Biol 147 (1999) 645-658
5. Brambilla P., Perez J., Barale F., Schettini G., and Soares J.C. GABAergic dysfunction in mood disorders. Mol Psychiatry 8 (2003) 721-737 [715]
6. Bray N.J., Buckland P.R., Owen M.J., and O'Donovan M.C. Cis-acting variation in the expression of a high proportion of genes in human brain. Hum Genet 113 (2003) 149-153
7. Bray N.J., Preece A., Williams N.M., Moskvina V., Buckland P.R., Owen M.J., et al. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum Mol Genet 14 (2005) 1947-1954
8. Bredt D.S. Knocking signalling out of the dystrophin complex. Nat Cell Biol 1 (1999) E89-E91
9. CavalliSforza L. The history and geography of human genes (1994)
10. Cohen J. Statistical power analysis for the behavioral sciences (1988) 8-14
11. D'Sa C., and Duman R.S. Antidepressants and neuroplasticity. Bipolar Disord 4 (2002) 183-194
12. DeRosse P., Funke B., Burdick K.E., Lencz T., Ekholm J.M., Kane J.M., et al. Dysbindin genotype and negative symptoms in schizophrenia. Am J Psychiatry 163 (2006) 532-534
13. Duan J., Martinez M., Sanders A.R., Hou C., Burrell G.J., Krasner A.J., et al. DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3′ end of the gene. Hum Hered 64 (2007) 97-106
14. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25 (2003) 115-121
15. Duman R.S., Malberg J., Nakagawa S., and D'Sa C. Neuronal plasticity and survival in mood disorders. Biol Psychiatry 48 (2000) 732-739
16. Fanous A.H., van den Oord E.J., Riley B.P., Aggen S.H., Neale M.C., O'Neill F.A., et al. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Am J Psychiatry 162 (2005) 1824-1832
17. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. Structured clinical interview for DSM-IV axis I disorders-clinician version (SCID-CV) (1997)
18. Funke B., Finn C.T., Plocik A.M., Lake S., DeRosse P., Kane J.M., et al. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am J Hum Genet 75 (2004) 891-898
19. Gornick M.C., Addington A.M., Sporn A., Gogtay N., Greenstein D., Lenane M., et al. Dysbindin (DTNBP1, 6p22.3) is associated with childhood-onset psychosis and endophenotypes measured by the Premorbid Adjustment Scale (PAS). J Autism Dev Disord 35 (2005) 831-838
20. Grady R.M., Zhou H., Cunningham J.M., Henry M.D., Campbell K.P., and Sanes J.R. Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin-glycoprotein complex. Neuron 25 (2000) 279-293
21. Kendler K.S. Schizophrenia genetics and dysbindin: a corner turned?. Am J Psychiatry 161 (2004) 1533-1536
22. Kendler K.S. "A gene for...": the nature of gene action in psychiatric disorders. Am J Psychiatry 162 (2005) 1243-1252
23. Knuesel I., Mastrocola M., Zuellig R.A., Bornhauser B., Schaub M.C., and Fritschy J.M. Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice). Eur J Neurosci 11 (1999) 4457-4462
24. Krystal J.H., Sanacora G., Blumberg H., Anand A., Charney D.S., Marek G., et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 7 Suppl 1 (2002) S71-S80
25. Mathews C.A., Reus V.I., Bejarano J., Escamilla M.A., Fournier E., Herrera L.D., et al. Genetic studies of neuropsychiatric disorders in Costa Rica: a model for the use of isolated populations. Psychiatr Genet 14 (2004) 13-23
26. McLeod T.M., Lopez-Figueroa A.L., and Lopez-Figueroa M.O. Nitric oxide, stress, and depression. Psychopharmacol Bull 35 (2001) 24-41
27. Morris DW, Murphy K, Kenny N, Purcell SM, McGhee KA, Schwaiger S, et al. Dysbindin (DTNBP1) and the Biogenesis of Lysosome-Related Organelles Complex 1 (BLOC-1): Main and Epistatic Gene Effects Are Potential Contributors to Schizophrenia Susceptibility. Biol Psychiatry in press.
28. Numakawa T., Yagasaki Y., Ishimoto T., Okada T., Suzuki T., Iwata N., et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet 13 (2004) 2699-2708
29. Purcell S., Cherny S.S., and Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 (2003) 149-150
30. Roberts R.G. Dystrophins and dystrobrevins. Genome Biol 2 (2001) [REVIEWS3006]
31. Schwab S.G., Knapp M., Mondabon S., Hallmayer J., Borrmann-Hassenbach M., Albus M., et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 72 (2003) 185-190
32. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 71 (2002) 337-348
33. Tang J.X., Zhou J., Fan J.B., Li X.W., Shi Y.Y., Gu N.F., et al. Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol Psychiatry 8 (2003) 717-718
34. Tochigi M., Zhang X., Ohashi J., Hibino H., Otowa T., Rogers M., et al. Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population. Neurosci Res 56 (2006) 154-158
35. Tosato S., Ruggeri M., Bonetto C., Bertani M., Marrella G., Lasalvia A., et al. Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 144 (2007) 647-659
36. Turunen J.A., Peltonen J.O., Pietilainen O.P., Hennah W., Loukola A., Paunio T., et al. The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland. Schizophr Res 91 (2007) 27-36
37. Van Den Bogaert A., Schumacher J., Schulze T.G., Otte A.C., Ohlraun S., Kovalenko S., et al. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet 73 (2003) 1438-1443
38. van den Oord E.J., Sullivan P.F., Jiang Y., Walsh D., O'Neill F.A., Kendler K.S., et al. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol Psychiatry 8 (2003) 499-510
39. Vilella E, Costas J, Sanjuan J, Guitart M, De Diego Y, Carracedo A., et al. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. J Psychiatr Res in press.
40. Williams N.M., Preece A., Morris D.W., Spurlock G., Bray N.J., Stephens M., et al. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry 61 (2004) 336-344
41. Zill P., Baghai T.C., Engel R., Zwanzger P., Schule C., Eser D., et al. The dysbindin gene in major depression: an association study. Am J Med Genet B Neuropsychiatr Genet 129 (2004) 55-58